Steroid Cessation Reverses Heart Wall Thickening in Weightlifters

Long-Term Steroid Exposure Impairs Ventricular Function

Continued use of anabolic-androgenic steroids (AAS) causes sustained thickening of the left heart wall and weakens both contraction and relaxation. The findings come from a follow-up study following recreational strength athletes for nearly ten years, published in European Heart Journal Cardiovascular Imaging. Lead author Dr. Vibeke M. Almaas from Oslo University Hospital tracked cardiac changes between athletes who persisted with steroid regimens and those who quit.

The left ventricle pumps oxygenated blood to the body, but sustained steroid exposure prevents the chamber from functioning properly. The heart muscle becomes unable to contract forcefully enough to expel blood, and it fails to relax between beats to refill. Dr. Almaas noted that 17 percent of athletes who continued using steroids developed severely reduced cardiac performance.

Dose Reductions Failed to Protect Heart Tissue

Lowering steroid dosages does not prevent progressive cardiac muscle thickening or restore normal pumping mechanics. Many athletes in the study reported reducing their overall intake between the initial assessment and the follow-up period. Ultrasonic imaging showed that these smaller doses produced the same pathological cardiac changes as higher doses.

Structural recovery occurred only when weightlifters discontinued steroids entirely. The data showed that partial harm reduction through lower dosing left the heart muscle enlarged and stiff. Full discontinuation, paired with medication for elevated blood pressure where appropriate, was the only approach linked to cardiac recovery.

Complete Cessation Restored Left Ventricular Mass

Stopping anabolic steroids reversed cardiac enlargement by 19 percent in weightlifters who chose full abstinence. Researchers evaluated left ventricular mass indexed to body surface area (LVMI) across all participants. Men who stopped taking steroids saw their average LVMI drop from 112 grams per square meter at baseline down to 91 grams per square meter at follow-up.

This 19 percent reduction brought their heart muscle dimensions back into the normal range observed in drug-free weightlifters. The non-user control group maintained an average LVMI matching that final 91 grams per square meter mark. The observation indicates that structural remodeling in the heart can regress once the hormonal stimulus stops.

Study Design and Participant Breakdown

Researchers re-enrolled 105 male strength athletes who took part in baseline assessments conducted between 2017 and 2019. The follow-up cohort included 70 previous steroid users and 35 drug-free recreational weightlifters who served as controls. Investigators invited an original pool of 101 users and 71 non-users back for testing.

Among the 70 returning steroid users, 35 continued active use, 15 stopped during the follow-up window, 14 stayed abstinent throughout, and 6 experienced a relapse. Clinicians gathered data through interviews, medical history reviews, hormone panels, urine testing, and echocardiograms. Athletes also reported their historical maximum weight lifted, duration of training, and other substance use to control for confounding variables.

Recovery Context and Clinical Caveats

Cardiovascular recovery after steroid exposure requires full discontinuation rather than unmonitored dosage adjustments. Beyond ventricular remodeling, steroid use causes dependence, hormonal suppression, liver strain, and blood vessel damage. Athletes working toward metabolic and cardiovascular recovery should discuss blood pressure management and cardiac screening with a physician.

The trial has limitations that warrant consideration. Drug use, dosage history, and training metrics relied partly on self-reported questionnaires and clinical interviews, which introduce recall inaccuracies. Further clinical trials are needed to determine whether functional pumping capacity recovers as completely as physical heart muscle dimensions.